Review Article
Characteristics of HLA-E Restricted T-Cell Responses and Their Role in Infectious Diseases
Table 2
T-cell properties of MHC class Ib restricted T-cells; phenotype, cytokine production, transcription factors, cytolytic molecules.
| | Antigen | T-cell phenotype | Cytokines | Transcr. factors | Function | Reference | CD3 | CD8 | TCRαβ | CD25 | LAG3 | CD39 | CTLA4 | CD45RA | CD45RO | CCR7 | CD27 | CD28 | CD56 | CD57 | CD62L | CD94 | Perforin | Granzyme A | Granzyme B | Granulysin | CD107a | TRAIL | TCR Vβ16 | TCR Vβ22 | IFNγ | TNFα | IL-2 | IL-4 | IL-5 | IL-10 | IL-13 | IL-17 | TGF-β | MIP-1β | T-bet | GATA3 | RORC | FOXP3 | EOMES | Spec. target lysis | Path. killing | T-cell suppr. | TM binding |
| Self | VMAPRTLVL | | + | + | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | + | | | | [42] |
| Self | VTAPRTVLL | | + | | | | | | | | | | | | | | | | | | | | | + | | | | | | | | | | | | | | | | | + | | | | [34] | VMAPRTLVL | | + | | | | | | | | | | | | | | | | | | | | | + | | | | | | | | | | | | | | | | | + | | | | VMAPRTLIL | | + | | | | | | | | | | | | | | | | | | | | | + | | | | | | | | | | | | | | | | | + | | | | VMAPRALLL | | + | | | | | | | | | | | | | | | | | | | | | + | | | | | | | | | | | | | | | | | + | | | | VMAPRTLFL | | + | | | | | | | | | | | | | | | | | | | | | + | | | | | | | | | | | | | | | | | + | | | |
| Self | VMAPRTLIL, VMAPRTLLL | | + | + | | | | | | | | | | + | | | + | | | | | | | | | | | | | | | | | | | | | | | | + | | | + | [35] |
| Self | QMRPVSRVL | | + | | | | | | | | | | | | | | | + | + | + | | | | | | | | | | | | | | | | | | | | | + | | | | [45] |
| Self | SLELGDSAL | | + | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | + | | | | [33] | LLLGPGSGL | | + | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | + | | | |
| EBV | SQAPLPCVL | | + | | | | | | | | | | | | | | | | | | | | | + | | | | | | | | | | | | | | | | | + | | | | [34] |
| EBV | SQAPLPCVL | | + | + | | | | | | | | | | + | | | + | | | | | | | | | | | | | | | | | | | | | | | | + | | | + | [35] |
| EBV | SQAPLPCVL | | + | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | + | [36] |
| CMV | VMAPRTLIL | | + | + | | | | | | | | | − | | | | | | | | | | | | | | | | | | | | | | | | | | | | + | | | + | [37, 39] |
| CMV | VMAPRTLIL | | + | | | | | | + | + | − | − | − | + | | | | + | | | | | | + | | + | | − | | | | | | | | | | | | | + | | | + | [38] |
| CMV | VMAPRTLIL, VMAPRTLVL | | + | | | | | | | | | | | | | | | | | | | | | + | | | | | | | | | | | | | | | | | | | | + | [12] |
| CMV | VMAPRTLLL | + | + | + | | | | | lo | hi | − | − | # | + | − | − | | + | + | + | | | | | + | + | + | | | | | | | | | | | | | | ? | | | + | [41] |
| CMV | VMAPRTLIL | | | | | | | | + | | | − | | | | | | + | | | | | | | | | | | | | | | | | | | | | | | | | | + | [40] |
| HCV | YLLPRRGPRL | | + | | | | | | | | | | | | | | | | | | | | | | | + | | | | | | | | | | | | | | | | | | | [44] |
| Salmonella | GMQFDRGYL | + | + | | | | | | | | | | | − | | | | | | + | | | | | | + | | | | | | | | | | | | | | | + | | | | [43] | AMLQDIATL | + | + | | | | | | | | | | | − | | | | | | + | | | | | | + | | | | | | | | | | | | | | | + | | | | KMLRGVNVL | + | + | | | | | | | | | | | − | | | | | | + | | | | | | + | | | | | | | | | | | | | | | + | | | | VEGEALATL | + | + | | | | | | | | | | | − | | | | | | + | | | | | | + | | | | | | | | | | | | | | | + | | | | AAVEELKAL | + | + | | | | | | | | | | | − | | | | | | + | | | | | | + | | | | | | | | | | | | | | | + | | | | AVAKAGKPL | + | + | | | | | | | | | | | − | | | | | | + | | | | | | + | | | | | | | | | | | | | | | + | | | | KLQERVAKL | + | + | | | | | | | | | | | − | | | | | | + | | | | | | + | | | | | | | | | | | | | | | + | | | |
| Salmonella | ? | + | + | | | | | | # | | | | | | | − | | | | | | + | | | | + | + | # | | | | | + | | + | | | | | | | | | | [46, 49] |
| Mtb | ? | | + | | | | | | | | | | | | | | | | | | | | | | | + | | | | | | | | | | | | | | | | | | | [31, 32] |
| Mtb | 69 peptides | + | + | + | + | + | | − | | | | | | | | | | # | | + | + | | | | | # | | | | | | | | | | | | | − | | + | | + | | [30] |
| Mtb | RMPPLGHEL | + | + | + | + | + | + | + | − | | + | | | | | | | # | + | + | + | | | | | # | + | # | # | + | # | + | | | | − | + | − | − | # | + | + | + | + | [47] | VLRPGGHFL | + | + | + | + | + | + | + | − | | + | | | | | | | # | + | + | + | | | | | # | + | # | # | + | # | + | | | | − | + | − | − | # | + | + | + | + |
| Mtb | VMTTVLATL | + | + | + | | | | | | | | | | | | | | − | | # | − | | # | | | − | + | − | # | − | − | + | − | | | | | | | | + | − | | + | [48] | RLPAKAPLL | + | + | + | | | | | | | | | | | | | | − | | # | − | | # | | | − | + | − | # | − | − | + | − | | | | | | | | + | − | | + | VMATRRNVL | + | + | + | | | | | | | | | | | | | | − | | # | − | | # | | | − | + | − | # | − | − | + | − | | | | | | | | + | − | | + | RMPPLGHEL | + | + | + | | | | | | | | | | | | | | − | | # | − | | # | | | − | + | − | # | − | − | + | − | | | | | | | | + | − | | + | VLRPGGHFL | + | + | + | | | | | | | | | | | | | | − | | # | − | | # | | | − | + | − | # | − | − | + | − | | | | | | | | + | − | | + |
|
|
|
“+” = positive in most samples; “−” = hardly seen; #: observed in about half of the samples; : membrane bound TGF-β, not secreted.
|